Injectable HIV Drug
![Injectable HIV Drug from ViiV Wins Over Patients in Switch Study](https://pharmtales.com/wp-content/uploads/2023/07/Patients-prefer-ViiVs-injectable-HIV-medication-according-to-a-Switch-research.jpg)
Patients prefer ViiV’s injectable HIV medication, according to a Switch research
SG Tylor
When ViiV Healthcare and Johnson & Johnson introduced their once-monthly injectable HIV treatment Cabenuva in 2021, they anticipated that patients ...